Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$607.51 USD

607.51
2,465,178

+58.20 (10.60%)

Updated Nov 7, 2024 04:00 PM ET

After-Market: $604.00 -3.51 (-0.58%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 22% (54 out of 251)

Industry: Medical - Dental Supplies

Zacks News

Syneos Health (SYNH) Q4 Earnings Top Estimates, Margins Down

Syneos Health (SYNH) reports better-than-expected earnings for the fourth quarter and strong performances by the Clinical Solutions and Commercial Solutions arms.

Globus Medical (GMED) Q4 Earnings Top Estimates, Gross Margin Up

Strength in Musculoskeletal Solutions and Enabling Technologies products drove Globus Medical's (GMED) Q4 revenues.

What Makes McKesson (MCK) a Strong Momentum Stock: Buy Now?

Does McKesson (MCK) have what it takes to be a top stock pick for momentum investors? Let's find out.

Henry Schein (HSIC) Q4 Earnings Top Estimates, Margins Grow

Robust performances by all three operating businesses drove Henry Schein's (HSIC) Q4 revenues.

Omnicell (OMCL) Q4 Earnings Miss Estimates, Revenues Beat

Robust performance by the Product and Service segments is driving Omnicell's (OMCL) fourth-quarter top line.

Should Value Investors Buy These Medical Stocks?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

3 Reasons Why McKesson (MCK) Is a Great Growth Stock

McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.

If You Invested $1000 in McKesson 10 Years Ago, This Is How Much You'd Have Now

Holding on to popular or trending stocks for the long-term can make your portfolio a winner.

Surging Earnings Estimates Signal Upside for McKesson (MCK) Stock

McKesson (MCK) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Are These Medical Stocks a Great Value Stocks Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Ideas feature highlights: Henry Schein, AmerisourceBergen and McKesson

Henry Schein, AmerisourceBergen and McKesson are included in this Investment Ideas blog.

Company News for Feb 4, 2022

Companies In The News Are: TMUS, MCK, ALL, AFL.

McKesson (MCK) Earnings and Revenues Beat Estimates in Q3

McKesson's (MCK) fiscal third-quarter 2022 results benefit from considerable growth across all segments.

McKesson (MCK) Q3 Earnings and Revenues Top Estimates

McKesson (MCK) delivered earnings and revenue surprises of 14.31% and 3.18%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Riya Anand headshot

Medical Products Stock Earnings on Feb 2: BSX, TMO & More

Medical Products companies' Q4 results are likely to reflect an increase in COVID-19 testing demand. Let's see how BSX, TMO, HOLX and MCK are poised ahead of their earnings releases.

McKesson (MCK) Hits 52-Week High: What's Aiding the Stock?

Investors are optimistic about McKesson's (MCK) strength in its Biologics business.

Is a Surprise Coming for McKesson (MCK) This Earnings Season?

McKesson (MCK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

McKesson (MCK) to Report Q3 Earnings: What's in the Cards?

McKesson's (MCK) fiscal third-quarter results are likely to reflect the solid show by the U.S. Pharmaceutical and Specialty Solutions segment.

McKesson (MCK) Gains As Market Dips: What You Should Know

McKesson (MCK) closed at $246.97 in the latest trading session, marking a +0.55% move from the prior day.

McKesson (MCK) Earnings Expected to Grow: Should You Buy?

McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here is Why Growth Investors Should Buy McKesson (MCK) Now

McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Should Value Investors Buy These Medical Stocks?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Will McKesson (MCK) Beat Estimates Again in Its Next Earnings Report?

McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Here's Why You Should Add Omnicell (OMCL) Stock for Now

Investors are optimistic about Omnicell (OMCL) on strength in medication management and adherence automation solutions.